Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section
NCT ID: NCT02279186
Last Updated: 2014-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
200 participants
INTERVENTIONAL
2014-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section
NCT02350179
Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section
NCT02739815
Tranexamic Acid for the Control of Blood Loss at Elective Cesarean Section
NCT03710330
Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
NCT02780245
The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery
NCT01085006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
receiving tranexamic acid
Tranexamic Acid
Intravenous Injection
group B
does not receive tranexamic acid
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tranexamic Acid
Intravenous Injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full term primiparas / multiparas.
* Singleton pregnancy being delivered by LSCS.
Exclusion Criteria
* Blood disorders.
* Allergy to tranexamic acid.
* History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia, uterine anomalies and pathology.
* Multiple pregnancy, macrosomia.
* Polyhydromnios .
* Patients requiring blood transfusion due to anemia
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams Maternity Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Mostafa Abdellah Mostafa
Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section ,A Randomized Clinical Trial.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amr Abdelaziz, M.D
Role: PRINCIPAL_INVESTIGATOR
Ain Shams Maternity Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Maternity Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nashwa AlSaied, M.D
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
septemper 2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.